Atlas Trials

A Study to Assess New Ebola Vaccines, cAd3-EBO Z and MVA-BN® Filo

Clinical trial NCT02240875 · COMPLETED

Trial details

NCT number
NCT02240875
Sponsor
University of Oxford
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
EbolaEbola Zaire
Start date
2014-09-17
Primary completion
2017-08-22
Enrollment
91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.